Deer Management Company’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Hold |
1,245,504
| – | – | 0.14% | 9 |
|
|
2025
Q1 | $1.72M | Hold |
1,245,504
| – | – | 0.16% | 9 |
|
|
2024
Q4 | $3.79M | Hold |
1,245,504
| – | – | 0.3% | 10 |
|
|
2024
Q3 | $6.2M | Hold |
1,245,504
| – | – | 0.98% | 10 |
|
|
2024
Q2 | $7.29M | Hold |
1,245,504
| – | – | 1.5% | 10 |
|
|
2024
Q1 | $9.89M | Sell |
1,245,504
-1
| -0% | -$8 | 1.79% | 11 |
|
|
2023
Q4 | $7.26M | Hold |
1,245,505
| – | – | 0.94% | 11 |
|
|
2023
Q3 | $3.19M | Hold |
1,245,505
| – | – | 0.39% | 12 |
|
|
2023
Q2 | $3.11M | Hold |
1,245,505
| – | – | 0.28% | 12 |
|
|
2023
Q1 | $2.62M | Hold |
1,245,505
| – | – | 0.24% | 12 |
|
|
2022
Q4 | $1.93M | Hold |
1,245,505
| – | – | 0.18% | 14 |
|
|
2022
Q3 | $3.8M | Hold |
1,245,505
| – | – | 0.27% | 13 |
|
|
2022
Q2 | $3.92M | Hold |
1,245,505
| – | – | 0.25% | 13 |
|
|
2022
Q1 | $3.49M | Hold |
1,245,505
| – | – | 0.12% | 15 |
|
|
2021
Q4 | $5.61M | Buy |
+1,245,505
| New | +$5.61M | 0.14% | 13 |
|